Advertisement

Topics

IQVIA Holdings Inc. Company Profile

04:35 EST 11th December 2018 | BioPortfolio

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare clients find better solutions for their patients. Formed through the merger of IMS Health and Quintiles, IQVIA offers a broad range of solutions that harness advances in healthcare information, technology, analytics and human ingenuity to drive healthcare forward. IQVIA enables companies to rethink approaches to clinical development and commercialization, innovate with confidence as well as accelerate meaningful healthcare outcomes. IQVIA has approximately 55,000 employees in more than 100 countries, all committed to making the potential of human data science a reality. IQVIA’s approach to human data science is powered by the IQVIA CORE™, driving unique actionable insights at the intersection of big data, transformative technology and analytics with extensive domain expertise. IQVIA’s insights and execution capabilities help biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures.


News Articles [512 Associated News Articles listed on BioPortfolio]

Roche to deploy IQVIA's technology suite in 100 countries

IQVIA announced that the pharmaceuticals division of Roche (F. Hoffmann─La Roche Ltd) has selected IQVIA's commercial technology suite for deployment across more than 100 markets. IQVIA's Technologi...

IQVIA Holdings, Inc. 2018 Q3 - Results - Earnings Call Slides

IQVIA Holdings, Inc. 2018 Q2 - Results - Earnings Call Slides

IQVIA Holdings Inc. (IQV) CEO Ari Bousbib on Q3 2018 Results - Earnings Call Transcript

IQVIA Holdings: Value Additions To R&D Industry Producing Revenue, Margin Growth

IQVIA Holdings, Inc. (IQV) CEO Ari Bousbib on Q2 2018 Results - Earnings Call Transcript

IQVIA Launches Commercial Content Management Solution IQVIA ePromo

Cloud-based solution accelerates and simplifies managing regulated promotional and non-promotional content for life sciences organizations IQVIA (NYSE:IQV), a company dedicated to applying advance...

IQVIA to Present at the Credit Suisse Annual Healthcare Conference on November 13, 2018

IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV), announced today that Michael McDonnell, executive vice president and chief financial officer, will speak at the Credit Suisse 27th A...

PubMed Articles [11 Associated PubMed Articles listed on BioPortfolio]

Antibiotic use on German pig farms - A longitudinal analysis for 2011, 2013 and 2014.

To study antibiotic use in livestock in a temporal context with the development of antimicrobial resistance, long-term changes in antibiotic use must be mapped and their possible causes must be explor...

Destroyed by Slavery? Slavery and African American Family Formation Following Emancipation.

This study introduces a new sample that links people and families across 1860, 1880, and 1900 census data to explore the intergenerational impact of slavery on black families in the United States. Sla...

Six-Year Prospective Outcomes of Primary Breast Augmentation With Nano Surface Implants.

Motiva Implants (Establishment Labs Holdings Inc.) are a novel family of silicone breast implants using cutting-edge technologies engineered to optimize aesthetic and safety outcomes.

Lovers, enemies, and friends: The complex and coded early history of lesbian comic strip characters.

This article seeks to recuperate four previously unexamined early newspaper comic strip characters that could lay the groundwork for queer comic studies. The titular characters in Lucy and Sophie Say...

The changing landscape of naloxone availability in the United States, 2011 - 2017.

Opioid overdose deaths have been on the rise in the United States since 1999. Naloxone is a competitive opioid antagonist that rapidly reverses opioid overdose. The implementation of naloxone access l...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Expanded Access With Trappsol(R) Cyclo (TM) for an Individual Patient With Late Onset Alzheimer's Disease

To afford urgent access to a potential-disease modifying treatment, Dr. Diana Kerwin, in partnership with CTD Holdings, the manufacturer of Trappsol (R) Cyclo(TM), will administer the prod...

Study of Pharmacokinetics and Preliminary Efficacy in Patients With Niemann-Pick C1

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann-Pick disease Type C1 (NPC-1) is safe at 3 different dose l...

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

This research study is being conducted to find out whether Trappsol® Cyclo™, an experimental treatment for people with Niemann Pick disease Type C (NPC-1) is safe at 2 different dose le...

Frequent Fallers' Experiences of an Adapted Walking Frame, Designed to Reduce the Walking Aid's Associated Falls Risk

For some patients with mobility issues, a walking frame (commonly known as a zimmer frame - trademark of Zimmer Holdings), is provided to keep them on their feet and help them remain more ...

Companies [468 Associated Companies listed on BioPortfolio]

IQVIA Holdings Inc.

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services focused on using data and science to help healthcare c...

IQVIA Inc.

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. Formed through the merger ...

Integra Holdings

Founded by Yissum, Integra Holdings is a unique venture fund, focusing on an exclusive selection of biotech companies with proprietary solutions and a competitive advantage in the...

Sabre Holdings

Sabre Holdings connects people with the world's greatest travel possibilities by retailing travel products and providing distribution and technology solutions for the travel indus...

HealthTech Holdings, Inc.

HealthTech Holdings, Inc. is a health information technology holding-company, with portfolio companies including HMS, MEDHOST and Sentry Healthcare Services, Inc. HealthTec...

More Information about "IQVIA Holdings Inc." on BioPortfolio

We have published hundreds of IQVIA Holdings Inc. news stories on BioPortfolio along with dozens of IQVIA Holdings Inc. Clinical Trials and PubMed Articles about IQVIA Holdings Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of IQVIA Holdings Inc. Companies in our database. You can also find out about relevant IQVIA Holdings Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record